Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

EC / List no.:
295-311-3
CAS no.:
91995-50-5
Index number:
Molecular formula:
SMILES:
InChI:
Type of substance:
UVCB
Origin:
Petroleum product
Registered compositions:
8
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
EINECS (European INventory of Existing Commercial chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (ATP01) approved by the European Union, this substance may be fatal if swallowed and enters airways, may cause genetic defects and may cause cancer.

Additionally, the classification provided by companies to ECHA in REACH registrations identifies that this substance causes damage to organs through prolonged or repeated exposure, is very toxic to aquatic life with long lasting effects, is toxic in contact with skin, is toxic if inhaled, is toxic if swallowed, is very toxic to aquatic life, is suspected of damaging fertility or the unborn child, causes serious eye irritation, is a highly flammable liquid and vapour, may cause respiratory irritation, causes skin irritation, may cause an allergic skin reaction and may cause drowsiness or dizziness.

Breakdown of all 48 C&L notifications submitted to ECHA

Repr. 2 H361
Aquatic Chronic 2 H411
Eye Irrit. 2 H319
STOT RE 1 H372
Acute Tox. 4 H312
STOT RE 2 H373
STOT SE 3 H335
Asp. Tox. 1 H304 Harmonised Classification
Acute Tox. 3 H331
Muta. 1B H340 Harmonised Classification
Carc. 1A H350
Aquatic Acute 1 H400
Aquatic Chronic 1 H410
Acute Tox. 4 H302
Acute Tox. 4 H332
https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/more.png 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

  • C
Officially recognised in the EU as Carcinogenic (Harmonised C&L).
  • C
There is no overall agreement among data submitters, but a minority indicate they consider this substance as Carcinogenic (25% of REACH registrations).
  • M
Officially recognised in the EU as Mutagenic (Harmonised C&L).
  • M
There is no overall agreement among data submitters, but a minority indicate they consider this substance as Mutagenic (25% of REACH registrations).
  • Ss
There is no overall agreement among data submitters, but a minority indicate they consider this substance as Skin sensitising (25% of REACH registrations).

Regulatory activities

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 6 active registrations under REACH, 1 Joint Submission(s) and 0 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Notification:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is manufactured and/or imported in the European Economic Area in 100 000 - 1 000 000 tonnes per year.

This substance is used by consumers, by professional workers (widespread uses), in formulation or re-packing, at industrial sites and in manufacturing.

This substance is used in the following products: fuels.

Other release to the environment of this substance is likely to occur from: indoor use in close systems with minimal release (e.g. cooling liquids in refrigerators, oil-based electric heaters) and outdoor use in close systems with minimal release (e.g. hydraulic liquids in automotive suspension, lubricants in motor oil and break fluids).

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or into which articles the substance might have been processed.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed processes with no likelihood of exposure, closed, continuous processes with occasional controlled exposure, closed batch processing in synthesis or formulation, in materials as fuel sources, with limited exposure to unburned product to be expected and batch processing in synthesis or formulation with opportunity for exposure.

Other release to the environment of this substance is likely to occur from: indoor use in close systems with minimal release (e.g. cooling liquids in refrigerators, oil-based electric heaters) and outdoor use in close systems with minimal release (e.g. hydraulic liquids in automotive suspension, lubricants in motor oil and break fluids).

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed processes with no likelihood of exposure, closed, continuous processes with occasional controlled exposure, closed batch processing in synthesis or formulation, transfer of substance into small containers, batch processing in synthesis or formulation with opportunity for exposure, laboratory work, mixing in open batch processes and production of mixtures or articles by tabletting, compression, extrusion or pelletisation.

Release to the environment of this substance can occur from industrial use: formulation of mixtures, manufacturing of the substance, formulation in materials, in processing aids at industrial sites, in the production of articles, as an intermediate step in further manufacturing of another substance (use of intermediates), as processing aid, for thermoplastic manufacture, as processing aid and of substances in closed systems with minimal release.

This substance has an industrial use resulting in manufacture of another substance (use of intermediates).

This substance is used in the following areas: formulation of mixtures and/or re-packaging. This substance is used for the manufacture of: chemicals.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed processes with no likelihood of exposure, closed, continuous processes with occasional controlled exposure, closed batch processing in synthesis or formulation, batch processing in synthesis or formulation with opportunity for exposure and laboratory work.

Release to the environment of this substance can occur from industrial use: as an intermediate step in further manufacturing of another substance (use of intermediates), of substances in closed systems with minimal release, manufacturing of the substance, in processing aids at industrial sites, formulation of mixtures, formulation in materials, in the production of articles, as processing aid, for thermoplastic manufacture and as processing aid.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed processes with no likelihood of exposure, closed, continuous processes with occasional controlled exposure, closed batch processing in synthesis or formulation, batch processing in synthesis or formulation with opportunity for exposure, laboratory work and transfer of substance into small containers.

Release to the environment of this substance can occur from industrial use: manufacturing of the substance, in processing aids at industrial sites, formulation of mixtures, formulation in materials, in the production of articles, as an intermediate step in further manufacturing of another substance (use of intermediates), as processing aid, for thermoplastic manufacture, as processing aid and of substances in closed systems with minimal release.

Precautions for using this substance have been recommended by its registrants under REACH, as follows:

Prevention statements

When handling this substance: do not handle until all safety precautions have been read and understood; take actions to prevent static discharges; do not breathe the dust, fume, gas, mist, vapours or spray; contaminated work clothing should not be allowed out of the workplace; keep away from heat, sparks, open flames and/or hot surfaces – No smoking; use only outdoors or in a well-ventilated area; obtain special instructions before use; do not eat, drink or smoke when using this product; avoid release to the environment; wash parts of the body (as specified by manufacturer/supplier)in contact with substance thoroughly after handling; wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier; avoid breathing the dust, fume, gas, mist, vapours or spray.

Response statements

In case of incident: Wash contaminated clothing before reuse. If swallowed: immediately call a poison center or doctor/physician. If exposed or concerned: get medical advice/attention. Get medical advice/attention if you feel unwell. If on skin (or hair): take off immediately all contaminated clothing. Rinse skin with water or shower. If inhaled: remove victim to fresh air and keep at rest in a position comfortable for breathing. Collect spillage. If swallowed: rinse mouth. Do not induce vomiting. If inhaled: call a poison center or doctor/physician if you feel unwell. If in eyes: rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. If eye irritation persists get medical advice/attention. Rinse the mouth. Do not induce vomiting. If swallowed: call a poison center or doctor/physician if you feel unwell. Follow specific treatment (see label).

Storage statements

Store this substance in a dry place; locked up; in a well-ventilated place and keeping container tightly closed.

Disposal statements

The substance must be disposed in accordance with local/regional/national/international regulation.

Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • Petroineos Manufacturing France SAS, Avenue de la Bienfaisance BP 6 133117 Lavera France
  • Shell Deutschland Oil GmbH, Suhrenkamp 71-77, 22335 Hamburg Germany
  • Total Olefins Antwerp, Scheldelaan 10 2030 Antwerpen Belgium
  • Total Petrochemicals France SA, Immeuble Le Linéa 1, rue du Général Leclerc 92047 Paris La Défence Cedex France
  • TOTAL RAFFINADERIJ ANTWERPEN NV, SCHELDELAAN 16, 2030 Antwerpen Belgium
  • Total Raffinage France, 2, place Jean Millier, La Défense 92400 Courbevoie France
  • INEOS Chemicals Grangemouth Ltd, PO Box 21 Bo,ness Road FK3 9XH Grangemouth Stirlingshire United Kingdom

Substance names and other identifiers

[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]
A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.
C&L Inventory
Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.
A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.
EU. Dangerous Substances - Eco-Labels
Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.; Low boiling point cat-cracked naphtha. [ complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]
A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.
EU. Worker Protection-Hazardous (98/24), EU. Pregnant Women Protection (92/85), EU. Hazardous Waste Properties: Annex III (2008/98/EC), EU. Young People at Work (94/33)
Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.; Low boiling point cat-cracked naphtha.
A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.
EU. Workplace Signs, EU. Carcinogens/Mutagens Directive (2004/37)
Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.
EC Inventory, C&L Inventory, REACH pre-registration, Other, EU. Cosmetics Regulation, Annex II, Prohibited Substances
Low boiling point cat-cracked naphtha.
A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.
C&L Inventory, EU. Dangerous Substances - Eco-Labels
(Keerulise koostisega süsivesinike segu, mis saadakse aurkrakitud raskbensiini kerge destillaadi töötlemisel. Koosneb peamiselt aromaatsetest süsivesinikest.] (et)
C&L Inventory
(Složeni sastav ugljikovodika dobiven obradom lakog destilata iz parno krekiranog benzina. Sastoji se pretežito od aromatskih ugljikovodika.) (hr)
C&L Inventory
[Kompleks blanding av hydrokarboner dannet ved behandling av et lett destillat fra dampkrakket nafta. Består hovedsakelig av aromatiske hydrokarboner.] (no)
C&L Inventory
[Kompleksna kombinacija ogljikovodikov dobljena z obdelavo lahkega destilata parno-krekirane nafte. Sestoji pretežno iz aromatskih ogljikovodikov.] (sl)
C&L Inventory
[komplexe Kombination von Kohlenwasserstoffen, erhalten durch Behandeln eines leichten Destillats aus dampfgekracktem Naphtha; besteht vorwiegend aus aromatischen Kohlenwasserstoffen] (de)
C&L Inventory
[Komplexná zmes uhľovodíkov získavaná úpravou ľahkého destilátu z parne krakovaného ťažkého benzínu. Pozostáva predovšetkým z aromatických uhľovodíkov.] (sk)
C&L Inventory
[O combinaţie complexă de hidrocarburi obţinute prin tratarea distilatului uşor din fracţia nafta cracată cu vapori. Constă cu precădere în hidrocarburi aromatice.) (mt)
C&L Inventory
[Ogļūdeņražu savienojumu komplekss, kas iegūts, apstrādājot ligroīna tvaika krekinga vieglo destilātu. Sastāv pārsvarā no aromātiskajiem ogļūdeņražiem.] (lv)
C&L Inventory
[Složitá směs uhlovodíků získaná zpracováním lehkého destilátu z pyrolyzovaného benzínu. Je složena převážně z aromatických uhlovodíků.] (cs)
C&L Inventory
[Sudėtinis angliavandenilių mišinys, gaunamas apdorojant pirminio benzino krekingo vandens garais lengvuosius distiliatus. Jį sudaro daugiausia aromatiniai angliavandeniliai.] (lt)
C&L Inventory
[Szénhidrogének komplex elegye, melyet gőzkrakkolt benzin könnyű desztillátumának kezelésével állítanak elő. Főleg aromás szénhidrogénekből áll.] (hu)
C&L Inventory
[Πολύπλοκος συνδυασμός υδρογονανθράκων που λαμβάνεται με κατεργασία ελαφρού αποστάγματος από ατμοπυρόλυση νάφθας. Συνίσταται κυρίως από αρωματικούς υδρογονάνθρακες.] (el)
C&L Inventory
[Комплексна комбинация от въглеводороди, получена при обработване с водород (хидротретиране) на лек дестилат от нискооктанов бензин от паров крекинг. Състои се основно от ароматни въглеводороди] (bg)
C&L Inventory
Alacsony forráspontú katalitikusan krakkolt benzin (hu)
C&L Inventory
combinación compleja de hidrocarburos obtenida por el tratamiento de destilado ligero de nafta craqueada a vapor; compuesta principalmente de hidrocarburos aromáticos (es)
C&L Inventory
Combinaison complexe d'hydrocarbures obtenue en traitant un distillat léger dérivé de naphta de vapocraquage. Se compose principalement d'hydrocarbures aromatiques. (fr)
C&L Inventory
Combinazione complessa di idrocarburi ottenuta per trattamento di un distillato leggero da nafta crackizzata a vapore. È costituita in prevalenza da idrocarburi aromatici. (it)
C&L Inventory
Combinação complexa de hidrocarbonetos obtida por tratamento de um destilado leve de nafta de steam cracking. É constituída predominantemente por hidrocarbonetos aromáticos. (pt)
C&L Inventory
destilados (petróleo), derivados del craqueo a vapor de nafta, fracciones aromáticas ligeras tratadas con hidrógeno (es)
C&L Inventory
Destilados (petróleo), nafta de steam cracking, compostos aromáticos leves tratados com hidrogénio (pt)
C&L Inventory
Destilati (nafta), dobiveni iz parnog krekinga teškog benzina, hidroobrađeni laki arom. (hr)
C&L Inventory
Destilati (zemeljsko olje), derivati parnega krekinga nafte, lahki aromatski obdelani z vodikom (sl)
C&L Inventory
Destillaadid (nafta), raskbensiini aurufaasilise krakkimise produkt, hüdrogeenitud, kerged aromaatsed (et)
C&L Inventory
Destillat (petroleum), nafta, ångkrackningsutvunna, vätebehandlade lätta aromatiska (sv)
C&L Inventory
Destillate (Erdöl), aus dampfgekracktem Naphtha, leicht, wasserstoffbehandelt, aromatisch (de)
C&L Inventory
Destillaten (aardolie), waterstofbehandelde aromatische lichte, afkomstig van het stoomkraken van nafta (nl)
C&L Inventory
destillater (petroleum), utvunnet fra dampkrakket nafta, hydrogenbehandlede, lette, aromatiske (no)
C&L Inventory
destillater (råolie), naphthadampkrakningsudvundne, hydrogenbehandlede lette aromatiske (da)
C&L Inventory
destiláty (ropné), z parného krakovania ťažkého benzínu, hydrogenované ľahké aromatické podiely (sk)
C&L Inventory
Destiláty (ropné), z pyrolýzy benzínu, hydrogenované lehké aromatické (cs)
C&L Inventory
Destilāti (nafta), tvaika krekingā iegūts ligroīns, apstrādāts ar ūdeņradi, vieglā aromātiskā frakcija (lv)
C&L Inventory
Destylaty węglowodorów aromatycznych lekkich (ropa naftowa), uwodornione pochodne z pirolizy benzyny (pl)
C&L Inventory
Desztillátumok (nyersolaj), benzin gőzkrakkolásból származó hidrogénezett könnyű arom. (hu)
C&L Inventory
Distilate (petrol), derivate ale fracţiei nafta cracată cu vapori, aromatice uşoare hidrotratate (mt)
C&L Inventory
Distiliatai (nafta), pirminio benzino krekingo vandens garais, hidrintų lengvųjų aromatinių angliavandenilių (lt)
C&L Inventory
distillati (petrolio), derivati da steam cracking di nafta, aromatici leggeri da hydrotreating (it)
C&L Inventory
Distillats aromatiques légers (pétrole), dérivés de vapocraquage de naphta, hydrotraités (fr)
C&L Inventory
Een complexe verzameling koolwaterstoffen, verkregen door het behandelen met waterstof van een licht destillaat uit stoomgekraakte nafta. Bestaat voornamelijk uit aromatische koolwaterstoffen. (nl)
C&L Inventory
En sammensat blanding af carbonhydrider opnået ved at behandle et let destillat fra dampkrakket naphtha. Den består overvejende af aromatiske carbonhydrider. (da)
C&L Inventory
Fracţia nafta cu punct de fierbere la temperaturi scăzute cracată catalitic (mt)
C&L Inventory
Katalitsko krekirana z nizko temperaturo vrelišča (sl)
C&L Inventory
katalyticky krakovaný ťažký benzín s nízkou teplotou varu (sk)
C&L Inventory
Katalytisch gekraakte nafta met laag kookpunt (nl)
C&L Inventory
katalytisch gekracktes Naphtha, niedrigsiedend (de)
C&L Inventory
Katalītiski sašķeltais ligroīns ar zemu viršanas temperatūru (lv)
C&L Inventory
Komplex blandning av kolväten erhållen genom behandling av ett lätt destillat från ångkrackad nafta. Består främst av aromatiska kolväten. (sv)
C&L Inventory
Lavtkogende katalytisk krakket nafta (da)
C&L Inventory
lavtkokende katalytisk krakket nafta (no)
C&L Inventory
Lågkokande katalytiskt krackad nafta (sv)
C&L Inventory
madala keemispunktiga katalüütiliselt krakitud raskbensiin (et)
C&L Inventory
Matalalla kiehuva katalyyttisesti krakattu teollisuusbensiini (fi)
C&L Inventory
Monimutkainen seos hiilivetyjä, saatu käsittelemällä kevyttä tislettä höyrykrakatusta teollisuusbensiinistä. Koostuu pääasiassa aromaattisista hiilivedyistä. (fi)
C&L Inventory
nafta craqueada catalíticamente de bajo punto de ebullición (es)
C&L Inventory
Nafta de baixo ponto de ebulição de cracking catalítico (pt)
C&L Inventory
nafta di cracking catalitico con basso punto di ebollizione (it)
C&L Inventory
naphta de craquage catalytique à point d'ébullition bas (fr)
C&L Inventory
Nisko-vrijući kat. krekiran benzin (hr)
C&L Inventory
Niskowrząca benzyna z krakingu katalitycznego (pl)
C&L Inventory
Nízkovroucí katalyticky krakovaná benzínová frakce (cs)
C&L Inventory
Tisleet (maaöljy), teollisuusbensiinistä höyrykrakkausjohdettu, vetykäsitellyt kevyet aromaatit (fi)
C&L Inventory
Złożona mieszanina węglowodorów otrzymywana przez obróbkę lekkiego destylatu z benzyny ciężkiej krakowanej z parą wodną. Składa się przede wszystkim z węglowodorów aromatycznych (pl)
C&L Inventory
Žematemperatūris katalizinio krekingo pirminis benzinas (lt)
C&L Inventory
αποστάγματαΑποστάγματα (πετρελαίου), προϊόντα ατμοπυρόλυσης νάφθας, ελαφρά κλάσματα αρωματικών ενώσεων, κατεργασμένα με υδρογόνο (el)
C&L Inventory
Νάφθα χαμηλού σημείου ζέσεως από καταλυτική πυρόλυση (el)
C&L Inventory
Дестилати (нефт), получени от нискооктанов бензин от паров крекинг; обработени с водород, леки ароматни (bg)
C&L Inventory
Нискооктанов бензин от каталитичен крекинг с ниска температура на кипене (bg)
C&L Inventory
Distillates (petroleum), naphtha steam cracking derived, hydrotreated light arom.
Registration dossier
Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom
Registration dossier
Hydrogenated B Cut
Registration dossier
hydrogénat moyen
Registration dossier
Essence coupe C7+
Registration dossier
Essence coupe TX Hydrostab
Registration dossier
Essence débenzénisée
Registration dossier
Hydrogenat moyen
Registration dossier
Hydrotreated C7-C9
Registration dossier
Pygas
Registration dossier
Pyrolysebenzin
Registration dossier
Pyrolysis gasoline
Registration dossier
649-293-00-2
Index number
C&L Inventory
91995-50-5
CAS number
EC Inventory, C&L Inventory, Registration dossier, REACH pre-registration, Other, EU. Worker Protection-Hazardous (98/24), EU. Cosmetics Regulation, Annex II, Prohibited Substances, EU. Dangerous Substances - Eco-Labels, EU. Pregnant Women Protection (92/85), EU. Workplace Signs, EU. Hazardous Waste Properties: Annex III (2008/98/EC), EU. Carcinogens/Mutagens Directive (2004/37), EU. Young People at Work (94/33)

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 24 studies submitted
  • 23 studies processed
C Physical state at 20°C and 1013 hPa
Liquid (100%) [23]
C Form
Other (89%), Viscous (11%) [9]
C Odour
Characteristic of aromatic compounds (76%), Other (19%), Faint (5%) [21]
C Substance type
Petroleum product (62%), Organic (38%) [21]

Type of Study provided
Studies with data
Key study 6 17
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Physical state at 20°C and 1013 hPa
Liquid (100%)

Melting/freezing point

Study results
  • 7 studies submitted
  • 6 studies processed
R Melting / freezing point
-100 - -29 °C @ 101.3 kPa [8]

Type of Study provided
Studies with data
Key study 6
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Melting / freezing point at 101 325 Pa
-66.9 °C

Boiling point

Study results
  • 21 studies submitted
  • 13 studies processed
R Boiling point
54.3 - 260 °C @ 100.7 - 101.33 kPa [15]

Type of Study provided
Studies with data
Key study 9 5
Supporting study 1 6
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Boiling point at 101 325 Pa
142 °C

Density

Study results
  • 13 studies submitted
  • 5 studies processed
R Relative density
0.83 - 0.89 @ 20 °C [5]

Type of Study provided
Studies with data
Key study 6
Supporting study 1 6
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Relative density at 20°C
0.87

Vapour pressure

Study results
  • 29 studies submitted
  • 21 studies processed
R Vapour pressure
4 - 550 hPa @ 20 - 50 °C [29]

Type of Study provided
Studies with data
Key study 21
Supporting study 3 5
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Vapour pressure
11.14 kPa @ 20 °C

Partition coefficient

Study results
  • 9 studies submitted
  • 7 studies processed
R Log Pow
2.2 - 6.5 @ -248.15 - 25 °C and pH 6.2 - 7 [7]

Type of Study provided
Studies with data
Key study 7
Supporting study 2
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Log Kow (Log Pow)
5.84 @ 20 °C

Water solubility

Study results
  • 6 studies submitted
  • 6 studies processed
R Water solubility (mass/vol.)
25 - 600 mg/L @ 20 °C and pH 5.2 - 9.1 [5]
R Water solubility (vol%)
0.1 - 0.7 vol% @ 20 °C and pH 6.4 [2]

Type of Study provided
Studies with data
Key study 6
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Water solubility
290 mg/L @ 20 °C

Solubility in organic solvents / fat solubility

Data not provided by the registrant

Surface tension

Study results
  • 6 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 6
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Surface tension at 20 °C
71.1 mN/m @ 243 mg/L

Flash point

Study results
  • 7 studies submitted
  • 7 studies processed
R Flash point
-30 - 43 °C @ 101.3 kPa [9]

Type of Study provided
Studies with data
Key study 7
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Flash point at 101 325 Pa
7.4 °C

Auto flammability

Study results
  • 6 studies submitted
  • 6 studies processed
R Autoflammability / self-ignition
401 - 502 °C @ 101.3 kPa [6]

Type of Study provided
Studies with data
Key study 6
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Autoflammability / self-ignition at 101 325 Pa
429 °C

Flammability

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Explosiveness

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidising

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Viscosity

Study results
  • 7 studies submitted
  • 6 studies processed
R dynamic viscosity (in mPa s)
0.45 - 0.95 [10]
R kinematic viscosity (in mm²/s)
0.54 - 1.5 [13]

Type of Study provided
Studies with data
Key study 6
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Dynamic viscosity at 20 °C
0.723 mPa.s

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Biodegradation in water
Under test conditions no biodegradation observed (100%)

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Bioaccumulation: aquatic / sediment

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Bioaccumulation Factor (BCF) - dimensionless
1 112

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

R Summaries
  • 1 summary submitted
  • 1 summary processed

The Predicted No-Effect Concentration (PNEC) value is the concentration of a substance below which adverse effects in the environment are not expected to occur. Please note that when more than one summary is provided, PNEC values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Hazard for Aquatic Organisms
Freshwater No data available: testing technically not feasible (1)
Intermittent releases (freshwater) No data available: testing technically not feasible (1)
Marine water No data available: testing technically not feasible (1)
Intermittent releases (marine water) No data available: testing technically not feasible (1)
Sewage treatment plant (STP) No data available: testing technically not feasible (1)
Sediment (freshwater) No data available: testing technically not feasible (1)
Sediment (marine water) No data available: testing technically not feasible (1)
Hazard for Air
Air Hazard related to composition of atmosphere identified (1)
Hazard for Terrestrial Organism
Soil No data available: testing technically not feasible (1)
Hazard for Predators
Secondary poisoning No potential for bioaccumulation (1)

Short–term toxicity to fish

Study results
  • 2 studies submitted
  • 1 study processed
P/RResults
LC50 (4 days) 1 mg/L [1]
LL50 (4 days) 1.1 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
LC50 for freshwater fish
1.1 mg/L

Long–term toxicity to fish

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Short–term toxicity to aquatic invertebrates

Study results
  • 2 studies submitted
  • 2 studies processed
P/RResults
EC50 (48 h) 1.2 - 2.7 mg/L [2]
EL50 (48 h) 1.2 - 3.3 mg/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
EC50 / LC50 for freshwater invertebrates
1.2 mg/L

Long–term toxicity to aquatic invertebrates

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to aquatic algae and cyanobacteria

Study results
  • 2 studies submitted
  • 2 studies processed
P/RResults
EC50 (4 days) 910 - 1 800 µg/L [4]
EC50 (72 h) 1.3 - 2 mg/L [2]
NOEC (4 days) 120 µg/L [1]
EL50 (4 days) 1.2 - 2.2 mg/L [4]
EL50 (72 h) 1.5 - 2.3 mg/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Sediment toxicity

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial plants

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to soil microorganisms

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to birds

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

M/C Summaries
  • 1 summary submitted
  • 1 summary processed

The derived no- or minimum effect level (DN(M)EL) is the level of exposure above which a human should not be exposed to a substance. Please note that when more than one summary is provided, DN(M)EL values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Data for WORKERS
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 3.25 mg/m³ carcinogenicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 23.4 mg/kg bw/day carcinogenicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: Low hazard (no threshold derived)
EYE Exposure
Low hazard (no threshold derived)
Data for the GENERAL POPULATION
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DMEL) 3.25 µg/m³ carcinogenicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
ORAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DMEL) 464 ng/kg bw/day carcinogenicity
Acute /short term: No hazard identified
EYE Exposure
No hazard identified

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 17 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study 5 1
Supporting study 6 2
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: dermal absorption
  • 7 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study 1
Supporting study 3 3
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Bioaccumulation potential:
Low bioaccumulation potential
Absorption values
Oral: 100 %
Dermal: 1 %
Inhalation: 50 %

Acute toxicity

Study results
oral
  • 8 studies submitted
  • 8 studies processed
P/RResults
LD50 512 - 6 631 mg/kg bw (rat) [10]
LD50 5 251 - 5 627 mg/kg bw (mouse) [2]
M/CInterpretations of results
Practically nontoxic [1]

Type of Study provided
oral
Studies with data
Key study 8
Supporting study
Weight of evidence
Other
Data waiving
no waivers
inhalation
  • 9 studies submitted
  • 9 studies processed
P/RResults
LC50 (6 h) 1.723 mg/L air (rat) [1]
LC50 (6 h) 284 - 353 ppm (rat) [2]
LC50 (4 h) 5.14 - 43.767 mg/L air (rat) [6]
LC50 (4 h) 5 922 - 13 700 ppm (rat) [6]
LC50 (6 h) 738.5 mg/m³ air (mouse) [1]
M/CInterpretations of results
Toxic [2]

inhalation
Studies with data
Key study 8 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
dermal
  • 7 studies submitted
  • 7 studies processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
LD50 2 000 - 12 126 mg/kg bw (rabbit) [4]
LD50 5 000 mL/kg bw (rabbit) [1]
M/CInterpretations of results
Practically nontoxic [2]

dermal
Studies with data
Key study 6
Supporting study
Weight of evidence 1
Other
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Oral route:
No adverse effect observed LD50 5 000 mg/kg bw
Inhalation route:
No adverse effect observed LC50 20 000 mg/m³
Dermal route:
No adverse effect observed LD50 2 000 mg/kg bw

Irritation / corrosion

Study results
Study data: skin
  • 8 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 2 5
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Study data: eye
  • 8 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study 3 1
Supporting study
Weight of evidence 3
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Skin
Adverse effect observed (irritating)
Eye
Adverse effect observed (irritating)
Respiratory
No adverse effect observed (not irritating)

Sensitisation

Study results
Study data: skin
  • 6 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 4
Supporting study
Weight of evidence 1
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Skin sensitisation
No adverse effect observed (not sensitising)
Respiratory sensitisation
No study available

Repeated dose toxicity

Study results
Study data: oral
  • 12 studies submitted
  • 8 studies processed
P/RResults
NOAEL (rat): 4 - 625 mg/kg bw/day [9]
NOAEL (mouse): 625 mg/kg bw/day [1]
LOAEL (rat): 25 - 1 250 mg/kg bw/day [4]
LOAEL (mouse): 1 250 mg/kg bw/day [1]

Type of Study provided
Study data: oral
Studies with data
Key study 6 2
Supporting study 2
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Study data: inhalation
  • 15 studies submitted
  • 13 studies processed
P/RResults
NOAEC (rat): 96 - 2 355 mg/m³ air [3]
NOAEC (rat): 30 - 7 000 ppm [12]
NOAEC (mouse): 32 - 96 mg/m³ air [2]
NOAEC (mouse): 5 - 2 000 ppm [5]
LOAEC (rat): 2.261 - 4.71 mg/L air [2]

Study data: inhalation
Studies with data
Key study 11 2
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
Study data: dermal
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Oral route - systemic effects:
Adverse effect observed LOAEL 25 mg/kg bw/day (subchronic, rat)

Genetic toxicity

Study results
Study data: in vitro
  • 24 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study 18 4
Supporting study 1
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: in vivo
  • 13 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study 4 7
Supporting study 1
Weight of evidence
Other 1
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Toxicity - InVivo
Adverse effect observed (positive)

Carcinogenicity

Study results
  • 12 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 7 5
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Oral route:
Adverse effect observed LOAEL 25 mg/kg bw/day (chronic, rat)
Inhalation route:
Adverse effect observed LOAEC 960 mg/m³ (chronic, mouse)

Toxicity to reproduction

Study results
Study data: reproduction
  • 9 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: reproduction
Studies with data
Key study 6 1
Supporting study 1
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: developmental
  • 16 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: developmental
Studies with data
Key study 11 3
Supporting study
Weight of evidence 1
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: other studies
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: other studies
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Neurotoxicity

Study results
  • 8 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 4 4
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Immunotoxicity

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant